US Pharm. 2012;37(4):1.
San Diego, CA—Researchers with the Scripps Clinic’s
Viterbi Family Sleep Center in San Diego have found that obesity
appears to significantly increase the risk of death tied to hypnotics.
Based on data from 40,000 U.S. patients, the use of sleep aids among
obese patients (average BMI >38.8) was associated with about one
extra death per year for every 100 people who were prescribed the drugs.
The mortality rate was 8.1 times higher on average among those who were
prescribed the smallest number of pills (18 or fewer annually) when
compared with similar study participants who did not take the drugs.
Obese patients appear particularly vulnerable, perhaps through
interaction with sleep apnea.
To comment on this article, contact email@example.com.
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date,
authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings,
including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations,
long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students,
other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn
Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE)
as a provider of continuing pharmacy education.
Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.